M. Miller

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study.

D. Doval, J. Jassem, G. von Minckwitz, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2 *

A. Armstrong, C. Griffiths, K. Reich, 2021, The British journal of dermatology.

Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trial.

K. Wilson, J. Gluckman, H. Saavedra, 1998, Archives of otolaryngology--head & neck surgery.